| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Quest Diagnostics Incorporated (DGX) has 15 insiders with recent SEC Form 4 filings, including 0 buys and 18 sells. DGX is classified in the Health Care Providers & Services industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 132.4K | $25.72M | -10,000 | |
| VP | 83.7K | $16.25M | - | |
| VP | 38.3K | $7.45M | - | |
| VP | 34.5K | $6.69M | - | |
| CFO | 33.4K | $6.48M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 25, 2021 | Prevoznik Michael E52 | SVP &General Counsel | Sell | 801 | $115.49 | $92,507.49 | -2.0% | |
| Feb 24, 2021 | Prevoznik Michael E52 | SVP &General Counsel | Sell | 1,188 | $116.95 | $138,936.60 | -1.4% | |
| Dec 24, 2020 | Guinan Mark | Executive Vice President &CFO | Sale+OE | 81,756 | $120.37 | $9,840,673.22 | -32.5% | |
| Nov 24, 2020 | Wilensky Gail R | Director | Sale+OE | 6,111 | $126.02 | $770,120.44 | -27.0% | |
| Nov 23, 2020 | Stanzione Daniel | Director | Sell | 11,223 | $126.30 | $1,417,458.52 | -10.8% | |
| Oct 21, 2020 | Deppe Michael J | VP, Corp. Controller &CAO | Sale+OE | 10,450 | $125.00 | $1,306,250.00 | -16.0% | |
| Oct 16, 2020 | Rusckowski Stephen H64 | Chairman, CEO And President | Sale+OE | 291,997 | $120.00 | $35,039,640.00 | -55.1% | |
| Oct 14, 2020 | Prevoznik Michael E52 | SVP &General Counsel | Sale+OE | 35,591 | $119.00 | $4,235,329.00 | -47.0% | |
| Sep 2, 2020 | Doherty Catherine T.55 | SVP, Group Exec. Clin. Fran. | Sale+OE | 58,392 | $110.60 | $6,458,342.82 | -29.3% | |
| Jun 8, 2020 | Guinan Mark | Executive Vice President &CFO | Sale+OE | 72,596 | $117.23 | $8,510,585.04 | -22.1% |